Redhill Biophrma ADR (RDHL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 8,043 | 6,530 | 61,800 | 85,757 | 64,359 |
| Cost of Goods | 3,192 | 3,459 | 33,337 | 49,406 | 36,892 |
| Gross Profit | 4,851 | 3,071 | 28,463 | 36,351 | 27,467 |
| Operating Expenses | 19,656 | -9,102 | 71,644 | 117,892 | 92,043 |
| Operating Income | -14,613 | 12,632 | -42,844 | -81,135 | -63,684 |
| Interest Expense | 2,056 | 9,605 | 42,387 | 16,660 | 12,759 |
| Other Income | 8,401 | 20,889 | 13,562 | 51 | 270 |
| Pre-tax Income | -8,268 | 23,916 | -71,669 | -97,744 | -76,173 |
| Net Income Continuous | -8,268 | 23,916 | -71,669 | -97,744 | -76,173 |
| Net Income | $-8,268 | $23,916 | $-71,669 | $-97,744 | $-76,173 |
| EPS Basic Total Ops | 0.00 | 100.00 | -1,200.00 | -2,100.00 | -2,100.00 |
| EPS Basic Continuous Ops | -6.71 | 92.30 | -1,162.93 | -2,100.79 | -2,091.08 |
| EPS Diluted Total Ops | 0.00 | 100.00 | -1,200.00 | -2,100.00 | -2,100.00 |
| EPS Diluted Continuous Ops | -6.71 | 92.30 | -1,162.93 | -2,100.79 | -2,091.08 |
| EPS Diluted Before Non-Recurring Items | -6.71 | 92.25 | -1,157.50 | -2,100.00 | -2,100.00 |
| EBITDA(a) | $-13,994 | $14,622 | $-34,690 | $-62,986 | $-61,974 |